Needham Downgrades Haemonetics to Hold
Needham analyst Mike Matson downgrades Haemonetics (NYSE:HAE) from Buy to Hold.
Morgan Stanley Maintains Equal-Weight on Haemonetics, Lowers Price Target to $60
Morgan Stanley maintains Haemonetics (NYSE:HAE) with a Equal-Weight and lowers the price target from $68 to $60.
Raymond James Maintains Outperform on Haemonetics, Lowers Price Target to $70
Raymond James analyst Andrew Cooper maintains Haemonetics (NYSE:HAE) with a Outperform and lowers the price target from $75 to $70.
75 Biggest Movers From Yesterday
Gainers
Society Pass Incorporated (NASDAQ: SOPA) surged 436.7% to settle at $48.30 on Tuesday after the company priced its IPO at $9 per share.
58 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Dover Motorsports, Inc. (NYSE: DVD) shares climbed 60.3% to $3.59 after Speedway Motorsports announced it will acquire the company for $3.61 per share in cash.
Looking Into Haemonetics’s Return On Capital Employed
According to Benzinga Pro, during Q2, Haemonetics (NYSE:HAE) earned $24.51 million, a 398.43% increase from the preceding quarter. Haemonetics also posted a total of $239.90 million in sales, a 4.97% increase since Q1.
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours:
Haemonetics Q2 Adj. EPS $0.60 Misses $0.61 Estimate, Sales $239.90M Miss $241.40M Estimate
Haemonetics (NYSE:HAE) reported quarterly earnings of $0.60 per share which missed the analyst consensus estimate of $0.61 by 1.64 percent. This is a 3.23 percent decrease over earnings of $0.62 per share from the same
Haemonetics Announced CFO William P. Burke to Retire in June 2022
Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that William P. Burke, Executive Vice President, Chief Financial Officer, has decided to retire from the Company. Mr.